GL1X · GenesisL1 explorer

MolNFT v2 · #147178 · protein

Discovery of MK-8353: An Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology

MolNFT v2 record #147178 on GenesisL1: PDB 6DCG, “Discovery of MK-8353: An Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology”. Protein, 366 residues. 3D structure, sequence proof, BLAST and structure search in GL1X.

PDB
6DCG
Type
protein
Length
366 residues
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.